About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Hematology/ Oncology and Stem Cell Therapy
›
top-articles
Hematology/ Oncology and Stem Cell Therapy
1.7
(top 50%)
impact factor
783
(top 20%)
papers
5.7K
(top 20%)
citations
29
(top 20%)
h
-index
1.8
(top 50%)
extended IF
880
all documents
6.2K
doc citations
48
(top 20%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Natural killer cells: In health and disease
Hematology/ Oncology and Stem Cell Therapy
2015
221
2
Cancer care in Jordan
Hematology/ Oncology and Stem Cell Therapy
2015
117
3
Long-term complications after hematopoietic cell transplantation
Hematology/ Oncology and Stem Cell Therapy
2017
116
4
The risk and prognosis of COVID-19 infection in cancer patients: A systematic review and meta-analysis
Hematology/ Oncology and Stem Cell Therapy
2020
97
5
Acinic cell carcinoma of the salivary glands: A literature review
Hematology/ Oncology and Stem Cell Therapy
2009
85
6
Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000–2010
Hematology/ Oncology and Stem Cell Therapy
2013
84
7
The immunoinhibitory B7-H1 molecule as a potential target in cancer: Killing many birds with one stone
Hematology/ Oncology and Stem Cell Therapy
2014
83
8
Emerging concepts in cytomegalovirus infection following hematopoietic stem cell transplantation
Hematology/ Oncology and Stem Cell Therapy
2017
78
9
Viral-associated thrombotic microangiopathies
Hematology/ Oncology and Stem Cell Therapy
2011
71
10
Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation
Hematology/ Oncology and Stem Cell Therapy
2012
71
11
Ruxolitinib for secondary hemophagocytic lymphohistiocytosis: First case report
Hematology/ Oncology and Stem Cell Therapy
2019
65
12
Prognostic Importance of C-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Systematic Review
Hematology/ Oncology and Stem Cell Therapy
2017
62
13
Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape
Hematology/ Oncology and Stem Cell Therapy
2017
60
14
Why implement universal leukoreduction?
Hematology/ Oncology and Stem Cell Therapy
2008
54
15
Hematopoietic stem cell transplantation for acute myeloid leukemia: A review
Hematology/ Oncology and Stem Cell Therapy
2017
54
16
The spectrum of noninfectious pulmonary complications following hematopoietic stem cell transplantation
Hematology/ Oncology and Stem Cell Therapy
2010
50
17
Cyclophosphamide plus total body irradiation compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation in patients with leukemia: a systematic review and meta-analysis
Hematology/ Oncology and Stem Cell Therapy
2011
50
18
Acute upper limb ischemia in a patient with COVID-19
Hematology/ Oncology and Stem Cell Therapy
2021
50
19
Standardization of rehabilitation after limb salvage surgery for sarcomas improves patients’ outcome
Hematology/ Oncology and Stem Cell Therapy
2013
46
20
Beliefs about hydroxyurea in youth with sickle cell disease
Hematology/ Oncology and Stem Cell Therapy
2018
43
21
Prevalence of HBV and HCV infection among multi-transfused Egyptian thalassemic patients
Hematology/ Oncology and Stem Cell Therapy
2012
41
22
Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myeloma
Hematology/ Oncology and Stem Cell Therapy
2011
39
23
Integrating mutation variant allele frequency into clinical practice in myeloid malignancies
Hematology/ Oncology and Stem Cell Therapy
2016
37
24
Secondary pulmonary alveolar proteinosis in hematologic malignancies
Hematology/ Oncology and Stem Cell Therapy
2014
36
25
Relevance of progesterone receptor immunohistochemical staining to Oncotype DX recurrence score
Hematology/ Oncology and Stem Cell Therapy
2016
35
26
Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia
Hematology/ Oncology and Stem Cell Therapy
2016
35
27
Cold agglutinin disease and autoimmune hemolytic anemia with pulmonary embolism as a presentation of COVID-19 infection
Hematology/ Oncology and Stem Cell Therapy
2020
34
28
Vitamin D baseline levels at diagnosis of breast cancer: A systematic review and meta-analysis
Hematology/ Oncology and Stem Cell Therapy
2021
34
29
Impact of vitamin D deficiency on increased blood eosinophil counts
Hematology/ Oncology and Stem Cell Therapy
2018
33
30
Ki-67 labeling index in glioblastoma; does it really matter?
Hematology/ Oncology and Stem Cell Therapy
2019
33
31
Retinoblastoma in Jordan: An epidemiological study (2006-2010)
Hematology/ Oncology and Stem Cell Therapy
2011
32
32
Hydroxyurea for nontransfusion-dependent β-thalassemia: A systematic review and meta-analysis
Hematology/ Oncology and Stem Cell Therapy
2017
31
33
Predictors of outcome in patients with hematologic malignancies admitted to the intensive care unit
Hematology/ Oncology and Stem Cell Therapy
2018
31
34
Eosinophilic fasciitis as a paraneoplastic syndrome, a case report and review of the literature
Hematology/ Oncology and Stem Cell Therapy
2014
30
35
Emerging natural killer cell immunotherapies: Large-scale ex vivo production of highly potent anticancer effectors
Hematology/ Oncology and Stem Cell Therapy
2010
29
36
Targeting the HER2 Receptor in Metastatic Breast Cancer
Hematology/ Oncology and Stem Cell Therapy
2012
29
37
Paraneoplastic neuromyelitis optica spectrum disorder associated with stomach carcinoid tumor
Hematology/ Oncology and Stem Cell Therapy
2014
29
38
Rare but authentic Philadelphia-positive acute myeloblastic leukemia: Two case reports and a literature review of characteristics, treatment and outcome
Hematology/ Oncology and Stem Cell Therapy
2015
29
39
Damocles’ syndrome revisited: Update on the fear of cancer recurrence in the complex world of today’s treatments and survivorship
Hematology/ Oncology and Stem Cell Therapy
2018
28
40
Hematopoietic cell transplantation for diffuse large B-cell and follicular lymphoma: Current controversies and advances
Hematology/ Oncology and Stem Cell Therapy
2017
27
41
Cost and quality issues in establishing hematopoietic cell transplant program in developing countries
Hematology/ Oncology and Stem Cell Therapy
2017
27
42
Standard management of sickle cell disease complications
Hematology/ Oncology and Stem Cell Therapy
2020
27
43
Leukemia during pregnancy: Long term follow up of 32 cases from a single institution
Hematology/ Oncology and Stem Cell Therapy
2014
26
44
The incidence rate of prostate cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from the Saudi Cancer Registry 2001–2008
Hematology/ Oncology and Stem Cell Therapy
2014
26
45
Expression of CD66c and CD25 in acute lymphoblastic leukemia as a predictor of the presence of BCR/ABL rearrangement
Hematology/ Oncology and Stem Cell Therapy
2008
25
46
Complications of hematopoietic stem transplantation: Fungal infections
Hematology/ Oncology and Stem Cell Therapy
2017
25
47
Early posttraumatic changes in coagulation and fibrinolysis systems in isolated severe traumatic brain injury patients and its influence on immediate outcome
Hematology/ Oncology and Stem Cell Therapy
2019
25
48
Current and future cancer burden in Saudi Arabia: meeting the challenge
Hematology/ Oncology and Stem Cell Therapy
2008
24
49
Evidence for the use PET for radiation therapy planning in patients with cervical cancer: a systematic review
Hematology/ Oncology and Stem Cell Therapy
2011
24
50
High-dose intravenous methotrexate in the management of breast cancer with leptomeningeal disease: Case series and review of the literature
Hematology/ Oncology and Stem Cell Therapy
2019
24
site/software ©
exaly
; All materials licenced under
CC by-SA
.